Me yasa FDA ke son Wannan Maganin Ciwon Opioid Kashe Kasuwa

Wadatacce

• Bita don

Bayanai na baya-bayan nan sun nuna cewa yawan shan miyagun kwayoyi a yanzu shi ne kan gaba wajen mutuwa a Amurkawa ‘yan kasa da shekaru 50. Ba wai kawai ba, amma adadin wadanda suka kamu da cutar na iya kaiwa wani matsayi a shekarar 2016, galibi daga magungunan opioid kamar tabar heroin. A bayyane yake, Amurka tana tsakiyar matsalar miyagun ƙwayoyi masu haɗari.

Amma kafin ki yi tunanin cewa a matsayinki na mace mai lafiya, mai aiki, wannan lamari bai shafe ki da gaske ba, ki sani cewa mata sun fi kamuwa da maganin kashe radadi, wanda sau da yawa kan haifar da haramtattun magungunan opioid irin su tabar heroin. Yawancin mutane ba su gane cewa shan magunguna masu zafi na likitanci don ainihin batun likita na iya haifar da mummunar ƙwayar ƙwayoyi, amma rashin alheri, sau da yawa yadda yake farawa. (Kawai tambayar wannan matar wacce ta ɗauki maganin kashe kuɗaɗe don raunin kwando ta kuma shiga cikin jarabar tabar heroin.)

Kamar kowane babban batun kiwon lafiya na ƙasa, maganin cutar ta opioid ba daidai ba ce. Amma saboda jaraba galibi yana farawa da yin amfani da masu rage zafin ciwo na halal, yana da ma'ana cewa masu kula da miyagun ƙwayoyi suna yin duban tsarukan da likitocin da majinyata ke da su a halin yanzu. A wani gagarumin yunkuri da aka yi a makon da ya gabata, Hukumar Kula da Abinci da Magunguna ta Amurka (FDA) ta fitar da wata sanarwa inda ta nemi a sake kiran wani maganin kashe radadi mai suna Opana ER. Ainihin, masana FDA sun yi imanin cewa haɗarin wannan maganin ya zarce duk fa'idodin warkewa.

Wannan yana yiwuwa saboda kwanan nan an sake fasalin maganin tare da sabon shafi don (na ban mamaki) hana mutanen da ke da jarabar opioid daga snorting shi. Sakamakon haka, mutane sun fara allurar ta a maimakon. Wannan hanyar isar da maganin ta hanyar allura tana da nasaba da barkewar cutar kanjamau da cutar hanta wato Hepatitis C, da dai sauran batutuwan da suka shafi lafiya masu tsanani da kuma masu yaduwa, a cewar sanarwar. Yanzu, FDA ta yanke shawarar tambayar Endo, wanda ya kera magungunan, don cire maganin daga kasuwa gaba ɗaya. Idan Endo bai bi ba, FDA ta ce za ta ɗauki matakai don cire maganin daga kasuwa da kansu.

Yana da wani m motsi a kan FDA ta bangaren, wanda, har zuwa yanzu, ba bisa ƙa'ida ya tashi zuwa yaki da yaki da opioid buri ta neman a tuna da wani magani domin rashin dacewa amfani. Samun kamfanonin magunguna su daina yin magungunan da ke haifar da babbar riba, duk da haɗari ga lafiyar jama'a, ba koyaushe ba ne mai sauƙi, ko da yake.

Wannan shine dalilin da ya sa kwamitin majalisar dattijai ke binciken kamfanonin magunguna don sanin matsayinsu a rikicin na ƙasa baki ɗaya. Kuma yayin da tabbas akwai amfani da warkarwa ga waɗannan magunguna, tare da gangara mai santsi da aka ambata a baya wanda shine jaraba da dogaro, yana da mahimmanci a sanar da ku game da haɗarin da ke tattare da shan maganin rage zafin ciwo, da kuma kula da alamun gargaɗin shan muggan ƙwayoyi.

Bita don